Kinetics analysis of tumor growth, quantified by bioluminescence imaging (Figure S1), revealed that OV-CXCR4-A exhibited significant therapeutic efficacy compared with the control OV-EGFP virus in WT and TgMISIIR-TAg-Low mice (Figure 1B; p = 0.02 and p = 0.04, respectively). This evidence concerns the gene CXCR4 and neoplasm.